drugset / Trial / NCT00440180

Aromatase Inhibitors in the Treatment of Male Infertility

NCT00440180

Phase 3 Terminated 20 enrolled University of Utah
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Obesity is associated with an increase in blood levels of estrogen. Estrogen or "female hormone" is believed to have a negative effect on sperm production. Aromatase inhibitors such as anastrozole work to decrease the production of estrogen and increase testosterone in the body. By decreasing the level of estrogen, sperm production should improve. In this study, the investigators will try to determine the benefit of anastrozole in obese men and follow pregnancy outcomes.

Timeline

Start
2007-03
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Anastrozole Other / unclassified 1 mg